GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Net Margin %

Novartis AG (Novartis AG) Net Margin %

: 72.01% (As of Dec. 2023)
View and export this data going back to 1996. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Novartis AG's Net Income for the three months ended in Dec. 2023 was $8,480 Mil. Novartis AG's Revenue for the three months ended in Dec. 2023 was $11,776 Mil. Therefore, Novartis AG's net margin for the quarter that ended in Dec. 2023 was 72.01%.

The historical rank and industry rank for Novartis AG's Net Margin % or its related term are showing as below:

NVSEF' s Net Margin % Range Over the Past 10 Years
Min: 13.58   Med: 21.57   Max: 54.63
Current: 28.64


NVSEF's Net Margin % is ranked better than
94.8% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.765 vs NVSEF: 28.64

Novartis AG Net Margin % Historical Data

The historical data trend for Novartis AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.10 16.18 54.63 16.00 31.83

Novartis AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.37 17.36 16.62 14.56 72.01

Competitive Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Novartis AG's Net Margin % falls into.



Novartis AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Novartis AG's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=14850/46660
=31.83 %

Novartis AG's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=8480/11776
=72.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG  (OTCPK:NVSEF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Novartis AG Net Margin % Related Terms

Thank you for viewing the detailed overview of Novartis AG's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (Novartis AG) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.